Breast cancer
Breast cancer is one of the most common malignant tumors in women, with an incidence rate of 7-10% of all malignant tumors in the body, second only to uterine cancer in women, and has become a major cause of threat to women's health. Its onset is often related to genetics, and the incidence rate is higher in women between the ages of 40 and 60, before and after menopause. It is one of the most common malignant tumors that usually occurs in breast glandular epithelial tissue, seriously affecting women's physical and mental health and even endangering their lives. Breast cancer in men is rare, with only about 1-2% of breast patients being male.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
Women aged 45-55, late menopause, over... -
Related symptoms:
Breast lumps Distant metastasis of breast cancer A palpable lump deep in the areola Swelling of axillary lymph nodes A peanut-sized lump on the lateral edge of the pectoralis major -
Concurrent disease:
Related Drugs
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Recombinant human interleukin-2 (125Ala) for injection
Indication: 1. It is used for the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, liver cancer, colorectal cancer, lymphoma, lung cancer, etc., and for the control of cancerous pleural effusion and ascites. It can also be used for the cultivation of lymphokine-activated killer cells.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Vinorelbine Tartrate for Injection
Indication: Non-small cell lung cancer, metastatic breast cancer and refractory lymphoma, ovarian cancer, head and neck tumors.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Vinorelbine Tartrate for Injection
Indication: Non-small cell lung cancer, metastatic breast cancer and refractory lymphoma, ovarian cancer, head and neck tumors.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Vinorelbine Tartrate for Injection
Indication: This product is suitable for patients with non-small cell lung cancer and breast cancer.
Vinorelbine Tartrate for Injection
Indication: Non-small cell lung cancer, metastatic breast cancer and refractory lymphoma, ovarian cancer, head and neck tumors.
Manufacturer:
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Vinorelbine Tartrate for Injection
Indication: Non-small cell lung cancer, metastatic breast cancer and refractory lymphoma, ovarian cancer, head and neck tumors.
Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:
Hainan Zhuotai Pharmaceutical Co., Ltd.
Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:
Hainan New Way Pharmaceufical Co., Ltd.
Related Ingredients